Characterization of prostatic neuroendocrine cell line established from neuroendocrine carcinoma of transgenic mouse allograft model
- 27 April 2004
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 62 (1) , 40-48
- https://doi.org/10.1002/pros.20111
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- An Allograft Model of Androgen Independent Prostatic Neuroendocrine Carcinoma Derived From a Large Probasin Promoter-T Antigen Transgenic Mouse LineJournal of Urology, 2004
- Molecular genetics of prostate cancerGenes & Development, 2000
- The Prognostic Value of Neuroendocrine Differentiation in Adenocarcinoma of the Prostate in Relation to Progression of Disease After Endocrine TherapyJournal of Urology, 1997
- Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patientsCancer, 1995
- Neuroendocrine cells in the normal, hyperplastic and neoplastic prostateUrological Research, 1995
- The Prostatic Endocrine-Paracrine (Neuroendocrine) Regulatory System and Neuroendocrine Differentiation in Prostatic Carcinoma: A Review and Future Directions in Basic ResearchJournal of Urology, 1994
- Establishment and Characterization of a Human Primary Prostatic Adenocarcinoma Cell Line (ND-1)Journal of Urology, 1992
- Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implicationsCancer, 1992
- Carcinoma of the ProstateNew England Journal of Medicine, 1991
- Relation of endocrine‐paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostateThe Prostate, 1991